Intersection of Biotechnology, Ethics, and the Law

From the Genome Project to the Next Generation – with Dr. Bob Cook-Deegan

44 min · 14. juli 2025
episode From the Genome Project to the Next Generation – with Dr. Bob Cook-Deegan cover

Description

In this episode of The Intersection of Biotechnology, Ethics & the Law, I’m joined by Dr. Bob Cook-Deegan—a pioneer in genomics, bioethics, and science policy. We talk about his role in the early days of the Human Genome Project, the ethical questions that have followed us since, and how challenges around gene ownership, public trust, and innovation are more relevant than ever. He also shares powerful advice for students like me who want to engage with science and its broader impact. It’s a wide-ranging, thoughtful conversation—and I’m excited to share it with you.

Comments

0

Be the first to comment

Sign up now and become a member of the Intersection of Biotechnology, Ethics, and the Law community!

Get Started

1 month for 9 kr.

Then 99 kr. / month · Cancel anytime.

  • Podcasts kun på Podimo
  • 20 lydbogstimer pr. måned
  • Gratis podcasts

All episodes

4 episodes

episode Biotech Startups, Policy, and the Law: A Conversation with Dr. Hans Sauer artwork

Biotech Startups, Policy, and the Law: A Conversation with Dr. Hans Sauer

What’s really at stake when a biotech startup tries to bring something new into the world? In this episode, I speak with Dr. Hans Sauer, Deputy General Counsel and Vice President for Intellectual Property at the Biotechnology Innovation Organization (BIO) and adjunct professor of law at Georgetown Law School. With a legal and scientific career spanning biotech patents, policy, and entrepreneurship, Dr. Sauer shares a big-picture view of what’s working—and what’s still unfolding—in today’s biotech landscape. We talk about the key legal and ethical questions facing biotech startups, how intellectual property influences innovation, and how the biotech sector is pushing law and policy to evolve. It’s a wide-ranging and grounded conversation about the real frameworks that shape biotech outcomes.

21. okt. 202554 min